Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc plus standard treatment for hospitalized patients with COVID-19 pneumonia
2020-002011-21Phase 2Active
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de Getafe
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of maraviroc in coronavirus pneumonia (2 arms), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de Getafe. Primary endpoint: Frequency of progression to severe ARDS. Started Jul 2020; status: active.
02
Drugs
maraviroc
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on 2020-002011-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002011-21.